Among other antitumor drugs in the HNC field, namely the epidermal growth factor receptor (EGFR) antibody cetuximab, an association between the adverse drug effect in the sense of acne-like skin changes and the therapy response is known (72, 73). This evidence concerns the gene EGFR and Abnormality of the skin.